Specialty Pharma ApS — Credit Rating and Financial Key Figures

CVR number: 38476599
Parcelvej 11, 2840 Holte
uhs@specialtypharma.dk
tel: 21127210
www.specialtypharma.dk

Income statement (kDKK)

2020
2021
2022
2023
2024
Fiscal period length1212121212
Net sales
Gross profit943.77639.301 023.44292.6996.40
Employee benefit expenses- 983.19- 704.77- 963.49- 183.75- 157.05
EBIT-39.42-65.4759.94108.94-60.66
Other financial expenses-0.03-0.50-1.70-2.49
Pre-tax profit-39.45-65.9758.24108.94-63.14
Income taxes21.74-17.12-28.259.38
Net earnings-39.45-44.2341.1380.69-53.76

Assets (kDKK)

2020
2021
2022
2023
2024
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current other receivables73.5218.82128.2596.13
Current deferred tax assets21.742.629.38
Short term receivables total73.5221.7421.44128.25105.51
Other current investments18.0018.00
Cash and bank deposits105.94101.8594.3434.0734.18
Cash and cash equivalents105.94101.8594.3452.0752.18
Balance sheet total (assets)179.46123.59115.78180.33157.69

Equity and liabilities (kDKK)

2020
2021
2022
2023
2024
Share capital50.0050.0050.0050.0050.00
Retained earnings6.37-33.08-77.31-36.1844.51
Profit of the financial year-39.45-44.2341.1380.69-53.76
Shareholders equity total16.92-27.3113.8294.5140.75
Non-current liabilities total
Short-term deferred tax liabilities25.63
Other non-interest bearing current liabilities162.54150.90101.9660.19116.94
Current liabilities total162.54150.90101.9685.82116.94
Balance sheet total (liabilities)179.46123.59115.78180.33157.69
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.